New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 14, 2012
10:00 EDTNOV, WYNN, ENDP, CIEN, ETH, IPAR, NDAQ, EZPW, CME, CLWR, ADBE, LEAP, XOM, BPOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: BP (BP) downgraded to Neutral from Outperform at Credit Suisse... CME Group (CME) downgraded to Underperform from Market Perform at Keefe Bruyette... Ciena (CIEN) downgraded to Market Perform from Outperform at BMO Capital... Exxon Mobil (XOM) downgraded to Neutral from Buy at Goldman... EZCORP (EZPW) downgraded to Neutral from Buy at Nomura... Endo Health (ENDP) downgraded to Underperform from Hold at Needham... Leap Wireless (LEAP) downgraded to Perform from Outperform at Oppenheimer... NASDAQ (NDAQ) downgraded to Market Perform from Outperform at Keefe Bruyette... Wynn Resorts (WYNN) downgraded to Neutral from Buy at UBS... Ethan Allen (ETH) downgraded to Hold from Buy at Stifel Nicolaus... Adobe (ADBE) downgraded to Neutral from Buy at Janney Capital... Inter Parfums (IPAR) downgraded to Average from Above Average at Caris... National Oilwell (NOV) downgraded to Neutral from Buy at Guggenheim... Clearwire (CLWR) downgraded to Neutral from Buy at Guggenheim.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
November 16, 2015
07:50 EDTADBEUBS to hold a conference
Subscribe for More Information
07:18 EDTWYNNDeutsche Bank to hold a conference
Subscribe for More Information
07:17 EDTNOVSeaport Global to hold a conference
Subscribe for More Information
07:16 EDTENDPHayman Capital gives quarterly update on stakes
NEW STAKES: Impax (IPXL), CF Industries (CF), GW Pharmaceuticals (GWPH), ProNAi Therapeutics (DNAI). INCREASED STAKES: BioMarin (BMRN), NMI Holdings (NMIH), Vertex (VRTX), Endo (ENDP). DECREASED STAKES: Mylan (MYL). LIQUIDATED STAKES: Perrigo (PRGO), Oasis Petroleum (OAS), Whiting Petroleum (WLL), Newfield Exploration (NFX), SM Energy (SM).
06:51 EDTBP, XOMBig energy firms saw 70% earnings dip for first nine months, WSJ says
Subscribe for More Information
06:08 EDTXOMExxon Mobil, Rosnet partnership is 'long-term,' Reuters reports
Subscribe for More Information
06:06 EDTENDPEndo downgraded to Neutral from Buy at Mizuho
Subscribe for More Information
November 15, 2015
19:24 EDTETHISS backs three Sandell nominees for Ethan Allen board, WSJ says
Proxy advisory firm Institutional Shareholder Services has recommended Ethan Allen shareholders vote for three of the six board candidates nominated by activist investment firm Sandell Asset Management, reports the Wall Street Journal. ISS noted that Sandell has made a "compelling case that change at the board level is warranted," the report adds. Reference Link
18:54 EDTNDAQNASDAQ to develop several 'blockchain' applications, Reuters says
Subscribe for More Information
November 13, 2015
15:49 EDTNDAQNASDAQ in talks to buy Chi-X Canada, Globe and Mail says
Subscribe for More Information
15:19 EDTNDAQNASDAQ in talks to buy Chi-X Canada, Bloomberg says
11:23 EDTENDPEndo management to meet with RBC Capital
Meeting to be held in Malvern, PA on November 16 hosted by RBC Capital.
10:49 EDTENDPMylan jumps, Perrigo plunges after hostile takeover bid fails
Shares of Mylan (MYL) jumped after the company's offer to acquire Perrigo (PRGO) failed. Perrigo shares fell after the news. WHAT'S NEW: Mylan's approximately $26B hostile takeover offer for Perrigo officially fell through Friday morning, ending a seven-month ordeal between the two companies. Mylan said that only about 40% of Perrigo's shares were tendered by the company's stockholders, falling short of the 50% required for an acquisition, forcing the offer to lapse after failing to meet its goal by the established deadline. In response to the news, Perrigo Chief Executive Officer Joseph Papa said he was "delighted" that his company's shareholders rejected the offer. "We have said all along that this offer from Mylan was a bad deal for our shareholders, as it significantly undervalued our durable business model and industry-leading future growth prospects," Papa said. Perrigo added that it will immediately commence its previously announced $2B share buyback and that it intends to complete $500M of the planned repurchase by the end of the year. WHAT'S NOTABLE: On July 27, Teva (TEVA) withdrew a takeover offer for Mylan amid Mylan's talks with Perrigo. The Israeli pharmaceutical company opted instead to purchase Allergan's (AGN) generics business. Commenting on its failure to buy Perrigo, Mylan Executive Chairman Robert Coury said in a statement that while the company viewed Perrigo as a "unique and exciting company," it was not required for the future success of the company. Coury said, "We are well-positioned to quickly execute on the next strategic, value-enhancing opportunities for our business, some of which we have already identified." STREET RESEARCH: Citi analyst Liav Abraham upgraded Mylan to Buy and raised her price target for shares to $59 from $52, saying that an overhang has been removed since the company's hostile attempt to buy Perrigo has fallen through. Abraham argued that a combination of the two companies would have been both destructive to both earnings and value for Mylan and that the failed bid will increase management's optionality to pursue other value-enhancing opportunities and enable investors to focus on the company's base business. In addition, RBC Capital Markets analyst Randall Stanicky confirmed a Sector Perform rating for both Mylan and Perrigo with price targets of $60 and $176, respectively. Stanicky said he expects Mylan's stock to gain 10%-15% towards $50 as a result of the news, while Perrigo will probably see a pull-back into the low $140s. The analyst added that the removal of the Mylan bid will drive initial weakness for Perrigo's shares but that the stock can settle close to its current levels. PRICE ACTION: In morning trading, Mylan rallied 12.5% to $48.60 and Perrigo fell 6.92% to $145.72. OTHERS TO WATCH: Teva shares trading in New York increased 0.26%, Allergan was up 0.66%, and Endo (ENDP), with which Reuters reported Perrigo held unsuccessful takeover talks, gained 5.56%.
10:00 EDTENDPEndo upgraded to Buy from Hold at Standpoint Research
Subscribe for More Information
06:23 EDTXOMExxon Mobil to start drilling in Liberia in 2017, Reuters reports
Subscribe for More Information
05:13 EDTXOMStocks with implied volatility movement; XRT XOM
Subscribe for More Information
November 12, 2015
16:18 EDTBPBP awards FleetCor long-term contract
FleetCor Technologies (FLT) announced that BP Products North America (BP) has extended its contract with FleetCor to provide commercial fleet card processing and program management for all of its fleet card products.
16:00 EDTXOMOptions Update; November 12, 2015
iPath S&P 500 VIX Short-Term Futures up 1.28 to 20.18. Option volume leaders: GE AAPL MNKD XOM BAC FB SUNE CSCO NFLX SYF BABA MSFT
12:42 EDTENDPPerrigo held unsuccessful talks to acquire Endo, Reuters reports
Perrigo (PRGO) has held unsuccessful talks to acquire Endo (ENDP) in all-stock deal, reports Reuters. According to people familiar with the matter, the talks were advanced enough for major issues such as the role of the Endo's CEO and how the companies could be integrated to have been addressed. Perrigo ended the talks when Endo asked for too much stock for its shareholders. Reference Link
08:48 EDTENDPEndo sued over birth control packaging error, CBS News reports
More than 100 women filed a class action lawsuit against Qualitest Pharmaceuticals, a subsidiary of Endo, over a birth control packaging error in 2011 that they claim led to unplanned pregnancies, reported CBS News. The suit seeks millions of dollars in damages, the report noted. Reference Link
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use